1 / 42

Lung Cancer Screening

<?xml version="1.0"?><AllQuestions />.

oksana
Télécharger la présentation

Lung Cancer Screening

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. <?xml version="1.0"?><AllQuestions /> <?xml version="1.0"?><Settings><answerBulletFormat>Numeric</answerBulletFormat><answerNowAutoInsert>No</answerNowAutoInsert><answerNowStyle>Explosion</answerNowStyle><answerNowText>Answer Now</answerNowText><chartColors>Use PowerPoint Color Scheme</chartColors><chartType>Vertical</chartType><correctAnswerIndicator>Checkmark</correctAnswerIndicator><countdownAutoInsert>No</countdownAutoInsert><countdownSeconds>10</countdownSeconds><countdownSound>TicToc.wav</countdownSound><countdownStyle>Box</countdownStyle><gridAutoInsert>No</gridAutoInsert><gridFillStyle>Answered</gridFillStyle><gridFillColor>255,255,0</gridFillColor><gridOpacity>100%</gridOpacity><gridTextStyle>Keypad #</gridTextStyle><inputSource>Response Devices</inputSource><multipleResponseDivisor># of Responses</multipleResponseDivisor><participantsLeaderBoard>5</participantsLeaderBoard><percentageDecimalPlaces>0</percentageDecimalPlaces><responseCounterAutoInsert>No</responseCounterAutoInsert><responseCounterStyle>Oval</responseCounterStyle><responseCounterDisplayValue># of Votes Received</responseCounterDisplayValue><insertObjectUsingColor>Blue</insertObjectUsingColor><showResults>Yes</showResults><teamColors>User Defined</teamColors><teamIdentificationType>None</teamIdentificationType><teamScoringType>Voting pads only</teamScoringType><teamScoringDecimalPlaces>1</teamScoringDecimalPlaces><teamIdentificationItem></teamIdentificationItem><teamsLeaderBoard>5</teamsLeaderBoard><teamName1></teamName1><teamName2></teamName2><teamName3></teamName3><teamName4></teamName4><teamName5></teamName5><teamName6></teamName6><teamName7></teamName7><teamName8></teamName8><teamName9></teamName9><teamName10></teamName10><showControlBar>Slides with Get Feedback Objects</showControlBar><defaultCorrectPointValue>100</defaultCorrectPointValue><defaultIncorrectPointValue>0</defaultIncorrectPointValue><chartColor1>187,224,227</chartColor1><chartColor2>51,51,153</chartColor2><chartColor3>0,153,153</chartColor3><chartColor4>153,204,0</chartColor4><chartColor5>128,128,128</chartColor5><chartColor6>0,0,0</chartColor6><chartColor7>0,102,204</chartColor7><chartColor8>204,204,255</chartColor8><chartColor9>255,0,0</chartColor9><chartColor10>255,255,0</chartColor10><teamColor1>187,224,227</teamColor1><teamColor2>51,51,153</teamColor2><teamColor3>0,153,153</teamColor3><teamColor4>153,204,0</teamColor4><teamColor5>128,128,128</teamColor5><teamColor6>0,0,0</teamColor6><teamColor7>0,102,204</teamColor7><teamColor8>204,204,255</teamColor8><teamColor9>255,0,0</teamColor9><teamColor10>255,255,0</teamColor10><displayAnswerImagesDuringVote>Yes</displayAnswerImagesDuringVote><displayAnswerImagesWithResponses>Yes</displayAnswerImagesWithResponses><displayAnswerTextDuringVote>Yes</displayAnswerTextDuringVote><displayAnswerTextWithResponses>Yes</displayAnswerTextWithResponses><questionSlideID></questionSlideID><controlBarState>Expanded</controlBarState><isGridColorKnownColor>True</isGridColorKnownColor><gridColorName>Yellow</gridColorName><AutoRec></AutoRec><AutoRecTimeIntrvl></AutoRecTimeIntrvl><chartVotesView>Percentage</chartVotesView><chartLabelsColor>0,0,0</chartLabelsColor><isChartLabelColorKnownColor>True</isChartLabelColorKnownColor><chartLabelColorName>Black</chartLabelColorName><chartXAxisLabelType>Answer Bullets</chartXAxisLabelType></Settings> <?xml version="1.0"?><AllAnswers /> Lung Cancer Screening David Koh, MD, FCCP March 1, 2014

  2. Objectives • Define the historical aspects of smoking and its relation to lung cancer • Describe the current process of lung cancer screening • State the newly recommended guidelines for lung cancer screening • Describe the new technology for the screening of lung cancer

  3. When did we know?

  4. Prevalence of Smoking • 1.3 billion smokers globally1. • 47% of men and 12% of women are smokers worldwide. • 45 Million adults in the US smoke2. • 23.5% males, 18.5% females. • There has been a decline in the percentage of smokers from 42% in 1965 to the 20.8% in 2006. 1. WHO Tobacco Free Initiative. 2004 2.CDC. MMWR 2005

  5. Cost of Smoking 157 billion dollars MMWR 2002

  6. What is in Smoke? • A pack-a-day smoker puffs more than 70,000 times a year. • 92-95% of the total weight of mainstream smoke is present in the gas phase. • Nitrogen, oxygen, and carbon dioxide account for 85% of smoke’s weight.

  7. Selected Cigarette Smoke Constituents in Particulate Phase

  8. Selected Cigarette Smoke Constituents in Gas Phase

  9. Mortality Rates • More than 399,000 US deaths annually are attributable to cigarette smoking. • Every 8 seconds, someone dies from tobacco use. • 40% of neoplasms are related to tobacco. • 22% of ischemic heart disease is caused by tobacco. • On average, male smokers lose 13.2 years and females lose 14.5 years of life expectancy CDC. MMWR. 2005

  10. CDC. MMWR. 2005

  11. CDC. MMWR. 2005

  12. Death Rates • Lung cancer accounts for 32% of all cancer deaths in men and for 25 % of all cancer deaths in women making lung cancer the leading cause of cancer deaths. • For women, incidence rates dropped for cancers of the breast, colon/rectum, uterus, ovary, cervix, and oral cavity but increased for cancers of the lung, thyroid, pancreas, brain/nervous system, bladder, and kidney, as well as for leukemia, non-Hodgkin lymphoma, and melanoma. CDC. MMWR. 2008

  13. Death Rates

  14. Top 12 States for New Lung Cancer Cases in 20121 • California (18,060) • Florida (17,860) • Texas (14,810) • New York (13,620) • Pennsylvania (10,890) • Ohio (10,270) • Illinois (9,190) • Michigan (8,210) • North Carolina (7,950) • Georgia (6,570) • Tennessee (6,140) • New Jersey (5,990) 1. 2012, American Cancer Society, Inc., Surveillance Research

  15. Local Lung Cancer

  16. Local Lung Cancer Rate

  17. Reality Then Carbone, PPNIH Conference Annals of Internal Medicine (1970) 73:1003 • At present lung cancer is recognized late. • Opportunities to improve survival are through earlier detection, accurate diagnosis, accurate localization, and curative therapy.

  18. Reality Now Sources: • NLST Research Team, N Engl J Med 365:395-409, 2011 • IELCAP Investigators, N Engl J Med 355:1763-1771, 2006 National Lung Screening Trial (NLST): • 8-year trial (2002 – 2010) compared low-dose ct screening to chest x-ray • 53,454 current/former smokers, at high risk for lung cancer • Results Released in November 2010: Those who received LDCT had a 20% lower risk of dying from lung cancer than those who received CXR.1 International Early Lung Cancer Action Program (I-ELCAP): • 31,567 current/former smokers, at high risk for lung cancer • 484 were diagnosed with lung cancer, 412 at Stage I • Results Published in October 2006: Over 80% of patients who have a lung cancer detected by CT screening can be cured. When the lung cancer is found early, and the patient receives surgical removal right away, the cure rate rises to 92%.2 International Association for the Study of Lung Cancer (IASLC): • “The publication of the NLST trial is a major turning point in lung cancer, which demonstrates the enormous potential of CT screening as an early detection tool, which, in combination with smoking cessation programs, is likely to have a major impact on lung cancer.” - Prof. John K Field, MA, PhD, BDS FRCPath, Chair of IASLC - June 29, 2011

  19. What was available • CT guided needle biopsy: • Pneumothorax reates reported anywhere from 10-60% with average of 25%. • In Ohno’s study, the lowest occurrences of PTX happened at a rate of 28.4% but a positive diagnosis in 77% when: • FEV1 > 70% • Single puncture • Needle path < 4 cm. Ohno, Y et al. AJR, AM J Roentgenology, 2003

  20. Ohno, Y et al. AJR, AM J Roentgenology, 2003

  21. Newer Bronchoscopy Techniques • EBUS: Endobronchial ultrasonography: Preferred method for sampling lymph nodes without general anesthesia. • ENB: Electromagnetic navigational bronchoscopy. Uses GPS to get to peripheral nodule. • Reconstruction guided bronchoscopy.

  22. Prior to Navigational Bronchoscopy • Eberhardt, R et al. Am J Resp Critical Care Medicine. 2007 • Schenk et al. Chest. 2003 • Schreiber, G et al. Chest. 2003 • Difficult to get to peripheral nodules because we were looking at a 2-D image. • PTX rates were lower at 4%1. • Positive diagnosis 402 -603 %

  23. Now With Navagational Bronchoscopy • Hogarth. Bronchol Intervent Pulmonal. 2011 • Minnich, DJ. Abstract at Society of Thoracic Surgeon’s Meeting. 2012 • For difficult cases, the yield was 77%1. • Overall, the ENB has an accuracy rate of 89% and a negative predictive value of 79%2.

  24. Electromagnetic Navigation Bronchoscopy (ENB)Procedure Overview CT-Scan DICOM CD Planning Software Planned Pathway File Navigation Biopsy Treatment

  25. Lung Cancer Screening • Released in April 2012: “Providing Guidance for Lung Cancer Screening: The ALA Interim Report on Lung Cancer Screening” • Key Points: • Best way to prevent lung cancer is to never start or quit smoking • Low Dose CT (LDCT) should be recommended for those meeting NLST criteria: • Current or former smoker, ages 55-74 • Smoking history of at least 30 pack-years • Those that smoked in the last 15 years. • No history of lung cancer • Individuals should not receive a Chest X-ray (CXR) for lung cancer screeningFor hospitals offering screening: • Ethical policies for advertising and promotion of screening should be set • Develop educational materials to assist patients in discussions on lung cancer screening • Provide screening services with access to a multidisciplinary team that can provide the needed follow-up evaluation of nodules

  26. What does the ACCT recommend?

  27. Take Home Message • For smokers with a greater than 30 pack years. • Current smokers and former smokers that quit less than 15 years ago. • Age 55-74 years old. • Annual Screening with low-dose CT annually.

  28. What about JAMA • Panel of experts from ACS, ACCP, ASCO and NCCN who reviewed 8 Randomized Clinical Trials and 13 Cohort Studies • 20% in each round of screening had a positive result, requiring some degree of follow-up and approximately 1% had lung cancer • Screening must be done in a center that has the capabilities to evaluate and management findings with a multidisciplinary team • Low Dose CT (LDCT) screening appears promising, but is also considered to be in it’s infancy • Quality Improvements measures should be reviewed to determine the “right” group to screen, how often and for how long

  29. Risks of Second Hand Smoke • 3,423-8,866 deaths from lung cancer. • 22,700-69,600 deaths from cardiac causes. • SIDS 430 deaths. • Childhood asthma (new and exacerbations) 202,300. • Increases risk of COPD by 55%2. • Doubles the risk of CVA3. CDC. Surgeon General’s Report. 2006. 2. Eisner, MD. Eviron Health. 2005. 3. Goldstein, LB. Stroke. 2006

  30. Conclusions • Lung cancer can now be reduced by 20%. • Cancer screening is the key to lowering deaths due to lung cancer by finding lung cancers at an early stage when lung cancer is still curable. • Who should be screened? • People from ages 55-74. • Greater than 30 pack years of smoking. • Smoked within 15 years. • No history of lung cancer. • Repeat CT for 3 consecutive years.

More Related